Chronic drug shortages across the European Union are causing significant challenges for pharmacists and patients, particularly in Belgium, where reports indicate an alarming scarcity...
The European Medicines Agency (EMA) has awarded orphan drug designation (ODD) to pegtarazimod (RLS-0071) for the treatment of patients suffering from graft-vs-host disease (GVHD)....